Instituto Nacional de Cancerología - Bogotá
Somos una institución del Estado colombiano en su orden nacional, que trabaja por el control integral del cáncer a través de la atención y el cuidado de pacientes, la investigación, la formación de talento humano y el desarrollo de acciones en salud públicaSelect an option
I am a doctor
I am a sponsor
Specializations
Cańcer
Our team
Medical staff
Osvaldo Sanchez
Laura Juliana Hernandez
Rosaura Bustamante
Fernando Contreras
Juan Alejandro Ospina
Felipe Fierro
Carlos Granados
Alexander Carreño
Open studies
Advanced tumors
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) - MK-7339-002 - AstraZenecaSee more
Prostate cancer
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer - Southwest Oncology GroupSee more
Solid tumors
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) - MK-7339-002 - AstraZenecaSee more
